Food and Drug Administration

Center for Biologics Evaluation and Research

 

SUMMARY MINUTES

VACCINES AND RELATED BIOLOGICAL PRODUCTS ADVISORY COMMITTEE

 

Meeting # 92:  November 18, 2002

 

 


Committee Members  

Dr. Robert Daum, Chair

Dr. Walter Faggett

*Ms. Barbara Loe Fisher

Dr. Judith Goldberg

Dr. Audrey Manley

Dr. Diane Griffin

Dr. Sam Katz

Dr. David Markovitz

Dr. Gary Overturf

Dr. Peter Palese

Dr. Julie Parsonnet

Dr. David Stephens

Dr. Rich Whitley

 

Members Not Present

+Dr. Michael Decker

Dr. Pamela Diaz

FDA Presenters

Dr. Richard Walker

Dr. Dennis Kopecko

Dr. Scott Stibitz

Dr. Philip Boucher

 

FDA Participants

Dr. Karen Midthun

Dr. Neil Goldman

 

Consultants

Dr. Estuardo Aguilar-Cordova

 

Executive Secretary

Dr. Jody Sachs

 


 

 

These summary minutes for the November 18, 2002 Meeting of the Vaccines and Related Biological Products Advisory Committee were approved on ______________________ .

 

I certify that I participated in the November 18, 2002 Meeting of the Vaccines and Related Biological Products Advisory Committee and that these minutes accurately reflect what transpired.

 

 

 

 

 

_____________________________                       ______________________________

Jody Sachs, D.P.M.                                                 Robert S. Daum, M.D.

Executive Secretary                                                          Chair


 

 

The Chair, Dr. Robert Daum, called the 92nd Meeting of the Vaccines and Related Biological Products Advisory Committee to order at 1:00 p.m. EST on November 18, 2002.   The meeting addressed the review of intramural research programs of the Laboratory of Enteric and Sexually Transmitted Diseases (LESTD), Office of Vaccines Research and Review (OVRR).

 

An Open Public Hearing session was announced.   No public comment was offered.

 

This meeting was held by a telephone conference call. The public was welcome to attend the open portion of the meeting at the Food and Drug Administration, Bldg 29B, Conference Room C, 29 Lincoln Drive, Bethesda, MD., for public participation. A speakerphone was provided at the specified location.

 

Following is a summary of the discussion. Additional information and specific details may be obtained from the transcript of the meeting.  The transcript may be viewed on the World Wide Web at: http://www.fda.gov/ohrms/dockets/ac/02acsdocs.htm.  A copy of the agenda is attached.

 

Proceedings were adjourned at approximately 2:40 p.m. EST on November 18, 2002.

 

Open Session

Brief Overview of the CBER Laboratories that underwent a Site Visit:

Dr. Richard Walker, Director of the Division of Bacterial, Parasitic & Allergenic Products presented an overview of the Division of Bacterial, Parasitic & Allergenic Products. Dr. Neil Goldman, Assoc. Director for Research in the Office of the Center Director, and Dr. Karen Midthun, Director, Office of Vaccines Research and Review responded to questions regarding the site visit process.

 

Dr. Dennis Kopecko, Chief of the Laboratory Enteric and Sexually Transmitted Diseases, (LESTD), presented an overview of all research and accomplishments from LESTD Laboratory.

 

Dr. Scott Stibitz and Dr. Philip Boucher then presented their laboratory research activities to the committee, followed by discussion.

 

The Closed Session followed.